1. Introduction {#sec1-molecules-21-00779}
===============

*Lobelia chinensis*, commonly known as Chinese lobelia, Herba Lobellae Chinensis, aze mushiro and mizo kakushi, grows wild throughout East Asia. It is one of the most used anti-cancer herbs in Chinese Medicine \[[@B1-molecules-21-00779]\]. Its chemical profile is very complex. The current phytochemical studies have found various types of chemical components, including piperidine alkaloids, coumarins, terpenoids and saponins \[[@B2-molecules-21-00779],[@B3-molecules-21-00779]\]. These chemicals show various biological activities, including anti-bacterial, anti-venom, anticancer, anti-viral and anti-inflammatory activities \[[@B4-molecules-21-00779],[@B5-molecules-21-00779],[@B6-molecules-21-00779],[@B7-molecules-21-00779],[@B8-molecules-21-00779]\]. In addition to these small molecules, this herb has a large amount of polysaccharides, the content of which can reach 25% by weight of the dry herb \[[@B9-molecules-21-00779]\]. Little is known about the chemistry and bioactivity of the polysaccharides of this herb.

Plant polysaccharides have shown many bioactivities \[[@B10-molecules-21-00779],[@B11-molecules-21-00779]\], whose ability to modulate immune function is popularly considered a major aspect. Many polysaccharides have been reported to be able to activate macrophages \[[@B12-molecules-21-00779],[@B13-molecules-21-00779],[@B14-molecules-21-00779]\], and this activation plays an important role in the immune response. The present study aims to analyze the chemistry of polysaccharides purified from the water extract of *Lobelia chinensis* and to explore their immune modulating effects on the RAW 264.7 cell line. A neutral α-glucan named BP1, with a molecular mass of approximately 9.45 kDa is isolated from *Lobelia chinensis*, and its chemical structure was characterized by chemical and spectral analyses. BP1 was able to enhance the cell proliferation, phagocytosis, nitric oxide production and cytokine secretion in a dose-dependent manner.

2. Results and Discussion {#sec2-molecules-21-00779}
=========================

2.1. Isolation and Purification of BP1 {#sec2dot1-molecules-21-00779}
--------------------------------------

Separation of the crude polysaccharide from *Lobelia chinensis* using fast-flow chromatography on Q-Sepharose generated five fractions: water, 0.2 M NaCl, 0.4 M NaCl, 1.0 M NaCl and 0.2 M NaOH fractions ([Figure 1](#molecules-21-00779-f001){ref-type="fig"}A). Further purification of the major fraction (0.2 M NaCl, 598 mg) using gel filtration chromatography on Superdex 75 ([Figure 1](#molecules-21-00779-f001){ref-type="fig"}B) yielded a purified polysaccharide, which was shown to be homogeneous in high performance gel permeation chromatography (HPGPC) ([Figure 1](#molecules-21-00779-f001){ref-type="fig"}C). We named this polysaccharide BP1. Its average molecular weight was determined to be approximately 9450 Da.

2.2. FT-IR Spectral Analysis {#sec2dot2-molecules-21-00779}
----------------------------

The FT-IR spectra of BP1 ([Figure S1](#app1-molecules-21-00779){ref-type="app"}) were analyzed as follows \[[@B15-molecules-21-00779]\]: a strong and broad peak at around 3367 cm^−1^ was attributed to the vibration of the O-H bond; a weak absorption peak at approximately 2932 cm^−1^ was attributed to the stretching vibration of C-H bond; these two signals characterized the absorption spectra of polysaccharides. Furthermore, the band at 1639 cm^−1^ can be attributed to the H-O-H bond, while the signals from 1453 cm^−1^ to 1332 cm^−1^ were attributable to --CH (O--CH~2~) flexural vibrations, according to \[[@B16-molecules-21-00779],[@B17-molecules-21-00779]\]. The band at 1131 cm^−1^ ws due to the C-O-C bond and glycosidic bridge, and the band at 1200 cm^−1^ and 1020 cm^−1^ might be given by the C--O stretching vibrations. The band at 846 cm^−1^ was ascribed to α-configuration of the polysaccharide. Absorption at 920 cm^−1^ indicated the existence of pyranose sugars \[[@B18-molecules-21-00779]\].

2.3. Protein Assay and Monosaccharide Composition Analysis {#sec2dot3-molecules-21-00779}
----------------------------------------------------------

BP1 was determined to be protein-free as measured via the Quick Start Bradford Protein Assay. The monosaccharide composition analysis using GC-MS indicated that BP1 was composed of glucose ([Figure 1](#molecules-21-00779-f001){ref-type="fig"}D).

2.4. Methylation Analysis {#sec2dot4-molecules-21-00779}
-------------------------

BP1 was subjected to methylation analysis to determine the linkage types \[[@B19-molecules-21-00779],[@B20-molecules-21-00779]\]. According to the methylated derivatives, as shown in [Table 1](#molecules-21-00779-t001){ref-type="table"}, the sugar residues of BP1 were determined to be 2,3,4,6-Me4-Glcp, 2,4,6-Me3-Glcp, 2,3,6-Me3-Glcp, 2,3,4-Me3-Glcp, 2,3-Me2-Glcp, 2,4-Me2-Glcp and 2-Me1-Glcp, indicating the existence of t-, 1,6-, 1,4-, 1,3-, 1,3,6-Glc, respectively.

2.5. NMR and Structure Analysis {#sec2dot5-molecules-21-00779}
-------------------------------

The ^1^H- and ^13^C-NMR spectra of BP1 were carefully assigned after an integrative consideration of the above-mentioned results, the 1D/2D-NMR spectra of BP1. The results are shown in [Table 2](#molecules-21-00779-t002){ref-type="table"}.

The anomeric signals were analyzed firstly. The proton signals around δ~H~ 4.83\~4.95 ppm and δ~H~ 5.18\~5.35 ppm in the ^1^H-NMR spectrum ([Figure 2](#molecules-21-00779-f002){ref-type="fig"}A) exhibited a peak area ratio of about 1.9:1; therefore the signals at δ~H~ 4.83\~4.95 ppm were considered to represent the main linkages of BP1. The anomeric carbon signals at δ~C~ 98.5\~100.0 ppm and δ~C~ 100.2\~101.4 ppm from ^13^C-NMR ([Figure 2](#molecules-21-00779-f002){ref-type="fig"}B) showed a peak area ratio of about 1.76:1, so the signals at δ~C~ 98.5\~100 ppm were attributed to the main anomeric carbon signals of BP1. It seems likely that the signals of δ~C~ 98.5\~100.0/δ~H~ 4.83\~4.95 were generated by 1,6-/1,3,6-linked Glc \[[@B21-molecules-21-00779],[@B22-molecules-21-00779],[@B24-molecules-21-00779]\], which were some of the major linkage types according to methylation analysis ([Table 1](#molecules-21-00779-t001){ref-type="table"}). This deduction was confirmed by the coupling of 98.5\~100.0/4.83\~4.95 in the HSQC spectrum ([Figure 3](#molecules-21-00779-f003){ref-type="fig"}B). The signals of δ~C~ 100.2\~101.4/δ~H~ 5.18\~5.35 were assigned to 1,3-/1,4-linked Glc and terminal Glc. In addition, compared to the published data of β*-*[d]{.smallcaps}-glucopyranose \[[@B20-molecules-21-00779],[@B25-molecules-21-00779]\], the anomeric signals of BP1 were significantly shifted up field, which indicated that BP1 has an α-configuration \[[@B26-molecules-21-00779]\]. This deduction was confirmed by the NOE interactions between H1 and H2 of residues 1,6-, 1,3,6- and 1,4-linked Glc.

In the DEPT-135 spectrum ([Figure 2](#molecules-21-00779-f002){ref-type="fig"}C), the signals at δ~C~ 66\~67 ppm were most likely due to the C6 of 1,6-/1,3,6-linked Glc, and the signals at δ~C~ 61.4\~61.8 ppm could be attributed to the C6 of 1,3-/1,4-linked Glc and terminal Glc. The signals at δ~C~ 78.0 may belong to the C4 of 1,4-linked Glc \[[@B23-molecules-21-00779]\], while the two peaks at δ~C~ 81 and δ~C~ 83 could be attributed to the C3 of 1,3-linked Glc and 1,3,6-linked Glc, because they were significantly shifted up field compared to the chemical shift of carbon with a free hydroxyl \[[@B27-molecules-21-00779],[@B28-molecules-21-00779]\].

The sequence of the monosaccharides in the sugar chain of BP1 was established by the analysis of the heteronuclear multiple bond correlation (HMBC) spectrum ([Figure 3](#molecules-21-00779-f003){ref-type="fig"}, [Table 3](#molecules-21-00779-t003){ref-type="table"}). For residue ~6~α-[d]{.smallcaps}-Glcp^1^, the anomeric proton showed a strong cross peak with the C6 of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^, and the anomeric carbon of residue ~6~α-[d]{.smallcaps}-Glcp^1^ also had a strong coupling with H6b of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^, which confirmed the presence of ~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^. The correlation between C1 of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^ and H6a of residue ~6~α-[d]{.smallcaps}-Glcp^1^ and that between the anomeric proton of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^ with C6a of residue ~6~α-[d]{.smallcaps}-Glcp^1^ further indicated the existence of ~6,3~α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^. These results suggest that the backbone of BP1 was composed of a ~6,3~α-[d]{.smallcaps}-Glcp^1^ linkage and a ~6~α-[d]{.smallcaps}-Glcp^1^ linkage.

Further, the interactions between C1 of residue ~4~α-[d]{.smallcaps}-Glcp^1^ with H3 of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^ and between H1 of residue ~4~α-[d]{.smallcaps}-Glcp^1^ with C3 of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^ indicated the presence of of ~4~α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^, suggesting that the side chain ~4~α-[d]{.smallcaps}-Glcp^1^ was linked to the backbone at O-3 of the residue ~3,6~α-[d]{.smallcaps}-Glcp^1^. In addition, C1 of residue ~4~α-[d]{.smallcaps}-Glcp^1^ also exhibited a strong coupling with H3 of residue ~3~α-[d]{.smallcaps}-Glcp^1^, which indicated the presence of ~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^. The trans-glycosidic correlation between C1 of residue ~3~α-[d]{.smallcaps}-Glcp^1^ and H4 of residue 4α-[d]{.smallcaps}-Glcp1, together with that between H1 of residue 3α-[d]{.smallcaps}-Glcp1 and C4 of residue ~4~α-[d]{.smallcaps}-Glcp^1^ proved the presence of ~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^. Since the ratio of the main residues ~4~α-[d]{.smallcaps}-Glcp^1^:~3~α-[d]{.smallcaps}-Glcp^1^ is about 2:1, a fragment of →~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^ may exist. Furthermore, the peak of ~4~α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^ was shown in HMBC, which allows one to infer that a side chain of →~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^ might be connected to the backbone through the O-3 site of ~3,6~α-[d]{.smallcaps}-Glcp^1^. Finally, the presence of α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^ was deduced from the correlation between C1 of residue α-[d]{.smallcaps}-Glcp^1^ and H3 of residue ~3,6~α-[d]{.smallcaps}-Glcp^1^. Another side chain was composed by α-[d]{.smallcaps}-Glcp^1^, which joined the backbone through the O-3 site of ~3,6~α-[d]{.smallcaps}-Glcp^1^.

More evidence regarding the precise structure of the sugar chain of BP1 was found in the NOESY (nuclear Overhauser effect spectroscopy) ([Figure 4](#molecules-21-00779-f004){ref-type="fig"}, [Table 4](#molecules-21-00779-t004){ref-type="table"}). The NOEs between AH1/BH6ab, DH1/CH4 and EH1/BH3 confirmed the deductions of ~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^, ~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^, and α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^, and NOEs between EH1/AH6ab and AH1/CH4 further confirmed the linkage of α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^, and ~6~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^. Based on the above evidence, the sequence of the residues of α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→ was proposed.

Taking all the NOE and HMBC evidence together, a side chain of α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→ could be proposed, which was confirmed by the analysis of the partial acid hydrolysis of BP1. The anomeric signals at δ~C~ 100.2\~101.4 and 98.5\~100.0 ppm showed a peak area ratio of about 1:1.76 in the ^13^C-NMR spectrum of BP1 ([Figure 2](#molecules-21-00779-f002){ref-type="fig"}B), and the ratio significantly decreased to 1:3.7 after partial acid hydrolysis ([Figure 2](#molecules-21-00779-f002){ref-type="fig"}D). These results suggest that ~4~α-[d]{.smallcaps}-Glcp^1^ and ~3~α-[d]{.smallcaps}-Glcp^1^ could be cut off from the main chain by partial acid hydrolysis, indicating that they might exist as side chains. This deduction was confirmed by the decreased signal around δ~C~ 78.0 ppm due to C4 of ~4~α-[d]{.smallcaps}-Glcp^1^.

Finally, with the aid of the ^1^H-^1^H COSY spectrum ([Figure 5](#molecules-21-00779-f005){ref-type="fig"}A) and the HSQC spectrum ([Figure 5](#molecules-21-00779-f005){ref-type="fig"}B), the ^1^D-NMR data were successfully assigned, and the results are presented in [Table 2](#molecules-21-00779-t002){ref-type="table"}. The methylation analysis indicated that BP1 mainly consists of residues ~6~α-[d]{.smallcaps}-Glcp^1^, ~3,6~α-[d]{.smallcaps}-Glcp^1^, ~4~α-[d]{.smallcaps}-Glcp^1^, ~3~α-[d]{.smallcaps}-Glcp^1^ and α-[d]{.smallcaps}-Glcp^1^. Based on methylation analysis, we concluded that the ratio of the main residues ~6~α-[d]{.smallcaps}-Glcp^1^:~3,6~α-[d]{.smallcaps}-Glcp^1^:~4~α-[d]{.smallcaps}-Glcp^1^:~3~α-[d]{.smallcaps}-Glcp^1^ is about 6:2:2:1. Therefore, we may infer that the backbone consists of residues following this order: →~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^-~6,3~α-[d]{.smallcaps}-Glcp^1^-~6~α-[d]{.smallcaps}-Glcp^1^→. A side chain is attached to the backbone through O-3 of residue B. There are two branches that were α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→ and terminal α-[d]{.smallcaps}-Glcp^1^→, which were located at the O-3 site of residue B (~3,6~α-[d]{.smallcaps}-Glcp^1^).

In summary, we conclude that the backbone consists of →~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^→(~6~α-[d]{.smallcaps}-Glcp^1^)x-~6,3~α-[d]{.smallcaps}-Glcp^1^-(~6~α-[d]{.smallcaps}-Glcp^1^)y→. The side chains were α-[d]{.smallcaps}-Glcp^1^→(~6~α-[d]{.smallcaps}-Glcp^1^)z→~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→ and α-[d]{.smallcaps}-Glcp^1^→, being attached to the backbone at O-3 of ~3,6~α-[d]{.smallcaps}-Glcp^1^. According to the linkage ratio, as revealed by the methylation analysis, the total sum of x, y and z should be five. Additionally, the molecular weight of BP1 suggested that n should be 3--4. The proposed structure is shown in [Figure 6](#molecules-21-00779-f006){ref-type="fig"}. A literature research indicated that the α-glucan BP1 is the first purified polysaccharide obtained and identified from *Lobelia*, even though this genus includes more than 415 species \[[@B29-molecules-21-00779]\].

2.6. MTT Assay {#sec2dot6-molecules-21-00779}
--------------

The results of the MTT assay of BP1's effect on the cell proliferation of RAW 264.7 cells are shown in [Figure 7](#molecules-21-00779-f007){ref-type="fig"}A. The positive control LPS induced cell proliferation, and polymyxin B (PolyB) stopped it. Like LPS, BP1 showed significant induction of the proliferation of RAW 264.7 cells, in a dose-dependent manner at concentrations of 12.5, 25, 50, 100 µg/mL, when administered together with PolyB in order to suppress the effect of LPS. The results suggest that LPS's impact could be excluded in the case of BP1.

2.7. Effect of BP1 on NO Release by RAW 264.7 Cells {#sec2dot7-molecules-21-00779}
---------------------------------------------------

In this study, the release of NO by RAW 264.7 cells after incubation with different concentrations of BP1 was determined ([Figure 7](#molecules-21-00779-f007){ref-type="fig"}B). As happens with LPS, BP1 also induced a strong NO release in a dose-dependent manner within the varied concentrations of 12.5, 25, 50, 100 µg/mL. PolyB inhibited the effect of LPS, but did not affect that of BP1.

2.8. Cytokine Production and the Role of TLR 4 {#sec2dot8-molecules-21-00779}
----------------------------------------------

Similar results were obtained in the determination of the effects of LPS and BP1 on the secretion of TNF-α and IL-6 by RAW 264.7 cells. LPS and LPS plus PolyB served as positive and endotoxin-excluded controls, respectively. The levels of TNF-α and IL-6 increased after LPS treatment and after BP1 + PolyB treatment ([Figure 7](#molecules-21-00779-f007){ref-type="fig"}C,D). When administrated with PolyB in order to suppress the effect of LPS, BP1 induced dose-dependent increases over the concentration range of 12.5, 25, 50, 100 μg/mL. Furthermore, when Toll-like receptor TLR 4 inhibitor (T4 Ihb) was added to the high-dose BP1 group (100 µg/mL), the production of both TNF-α and IL-6 was significantly suppressed, but the TLR 4 control (100 + T4 Con) did not show such significant difference. These results suggested that TLR 4 may play an important role in the signal transduction.

2.9. Assay of Phagocytosis {#sec2dot9-molecules-21-00779}
--------------------------

The effect of BP1 on the phagocytosis to FITC-dextran by RAW 264.7 cells is shown in [Figure 8](#molecules-21-00779-f008){ref-type="fig"}. LPS and LPS plus PolyB served as positive and endotoxin-excluded controls, respectively. LPS at 2 µg/mL significantly induced the phagocytosis, and PolyB stopped it. BP1 at concentrations of 200 and 400 μg/mL, when administrated with PolyB in order to suppress the impact of LPS, induced the phagocytosis to FITC-dextran by RAW 264.7 cells.

Generally speaking, the bioactivities of polysaccharides are closely dependent on their structures, including monosaccharide composition and sequence, glucosidic bonds, configuration and chain conformation \[[@B30-molecules-21-00779],[@B31-molecules-21-00779],[@B32-molecules-21-00779]\]. However, it has not been clear if the pattern-recognition receptors of the cell membrane might be specific to the α,β-configuration of polysaccharides. It has been known that Dectin-1 is the receptor responsible for the recognition of both β-(1,3) glucans \[[@B33-molecules-21-00779]\] and α-(1,3) glucans \[[@B34-molecules-21-00779]\]. TLR2 is the receptor responsible for the recognition of both β-(1,3) glucans \[[@B35-molecules-21-00779]\] and α-(1,4) glucans \[[@B36-molecules-21-00779]\]. TLR4 is the receptor responsible for the recognition of α-(1,4,6)-glucan \[[@B37-molecules-21-00779]\]. In this study, TLR4 was found to be a potential receptor for the α-glucan BP1. Because it is not known whether TLR4 functions as a receptor for β-glucan, we cannot say whether TLR4 is configuration-specific. Therefore, some more research is still needed to determine the role of TLR4 in the immuno-modulating effects of β-glucans.

3. Materials and Methods {#sec3-molecules-21-00779}
========================

3.1. Materials {#sec3dot1-molecules-21-00779}
--------------

Samples of Herba Lobellae Chinensis, *i.e.*, dried *Lobelia chinensis*, were provided by the Kang Qiao Traditional Chinese Medicine Decoction Pieces Co. Ltd. (Shanghai, China), China, and were identified by Prof. Zhili Zhao (Shanghai University of Traditional Chinese Medicine, Shanghai, China 131120). Monosaccharide standards were all from Fluka, USA. Dextran standards and trifluoroacetic acid (TFA) and dimethyl sulfoxide (DMSO) were from Sigma-Aldrich (St. Louis, MO, USA). Other reagents were analytical grade and obtained from China Chemical Reagent Industry (Shanghai, China), unless otherwise specified.

3.2. Isolation and Purification of BP1 {#sec3dot2-molecules-21-00779}
--------------------------------------

The dried herbs of *L. chinensis*, samples of approximately 1.0 kg, were weighed accurately, crushed and then refluxed in absolute ethanol at 80 °C for 2 h. The residues were extracted twice with 5 L of distilled water at 100 °C for 3 h. After centrifuging at 4000 rpm for 10 min, the supernatant was collected and condensed to 100 mL by rotary evaporation at 60 °C. The concentrated solution was precipitated overnight with four volumes of 95% EtOH in a refrigerator (4 °C). After centrifuging at 4000 rpm for 10 min, the precipitate was collected and freeze-dried, yielding crude polysaccharides (126 g).

A part of the crude polysaccharide (10 g) was dissolved in distilled water (50 mL) in a water bath at 60 °C and the solution was centrifuged at 12,000 rpm for 10 min. The above operation was repeated again. The supernatant (10 mL) was loaded onto a Q-Sepharose Fast Flow column (50 cm × 5 cm), which was eluted stepwise with distilled water, followed by 0.2 M and 0.4 M NaCl solution and the eluate was monitored using the phenol-sulfuric acid method \[[@B38-molecules-21-00779],[@B39-molecules-21-00779],[@B40-molecules-21-00779]\]. The major fraction (the part of 0.2 M NaCl) was dialyzed with flowing tap-water and freeze-dried using a lyophilizer (Labconco, Kansas City, MO, USA). This fraction was further separated using a Superdex-75 column (100 cm × 2.5 cm), eluted with 0.2 M NaCl solution and monitored using an RI-102 refractive index detector (Lihui Biological Technology Co., Ltd., Suzhou, China). The fractions obtained (220--260 min) were combined, concentrated, dialyzed against flowing tap-water and lyophilized to obtain the major fraction BP1 (1.25 g).

3.3. Determination of the Molecular Weight {#sec3dot3-molecules-21-00779}
------------------------------------------

The molecular weight of the BP1 was estimated through high performance gel permeation chromatography (HPGPC) (Tosoh Bioscience, King of Prussia, PA, USA) by using combined columns of Shodex KS-802 and KS-804, which were eluted with a mobile phase of 0.2 M NaCl at a flow rate of 0.8 mL/min. The eluate was monitored by RI detector (RI-101 refractive index detector). To estimate the molecular weight, Shodex-packed columns were calibrated using a standard P-series of dextrans (P-5, P-10, P-20, P-50, P-100, P-200, P-400 and P-800). The molecular weight was calculated according to the method of Fan *et al.* and Liu *et al.* \[[@B41-molecules-21-00779],[@B42-molecules-21-00779]\].

3.4. Determination of the Protein Content {#sec3dot4-molecules-21-00779}
-----------------------------------------

The protein contents of the polysaccharide samples were determined using Quick start Bradford 1× Dye Reagent (Bio-Rad, Hong Kong, China). A standard curve was prepared with bovine serum albumin (BSA, 0--2.0 mg/mL). BP1 polysaccharide was dissolved in deionized water at a concentration of 2.0 mg/mL. The sample was mixed with diluted dye reagent and incubated at room temperature for 5 min. Then, the absorbance was measured at 595 nm using a microtiter plate reader.

3.5. Monosaccharide Composition Analysis {#sec3dot5-molecules-21-00779}
----------------------------------------

BP1 (2 mg) was hydrolyzed in 2 M TFA (2 mL) at 120 °C for 2 h in a sealed glass tube. The acid was removed under reduced pressure through repeated evaporation with MeOH. The hydrolysate was successively reduced with sodium borohydride, acetylated with acid anhydride (Ac~2~O) at 105 °C for 1 h, and the resulting alditol acetates were examined via GC-MS.

The gas chromatography-mass spectrometry (GC-MS) was performed on a Shimadzu QP-2010 instrument equipped with a Shimadzu AOC-20i auto sampler system and interfaced with a Shimadzu QP 2010S mass spectrometer (Shimadzu Corporation, Tokyo, Japan). Samples were injected in splitless mode on a DB-5 MS analytical column (30 m × 0.25-mm ID with a film thickness of 0.25-μm J & W Scientific, Folsom, CA, USA). Helium (purity, 99.999%) was used as a carrier gas at a constant flow rate of 1 mL/min. The gas chromatograph was operated in split mode with the split/splitless injector at the ratio of 1:5. The injector temperature was set at 250 °C. The temperature program was set at 140 °C, maintained for 5 min and increased to 250 °C for 5 min at an increment of 3 °C/min. The mass spectra were taken in SCAN mode at 300 eV from *m*/*z* 40 to 400, and the scan speed was 769 while the detector delayed for 5 min. The MS progress started at 5 min and ended at 44 min. Standard monosaccharides were carried out following the same procedure.

3.6. Methylation Analysis {#sec3dot6-molecules-21-00779}
-------------------------

Methylation analysis was carried out according to the modified Hakomori method \[[@B43-molecules-21-00779]\]. Briefly, BP1 (10 mg) was accurately weighed and dissolved in 1.0 mL of DMSO, to which 1.0 mL of dimsyl sodium (SMSM, 0.25 g/mL) solution was added under water-free conditions. After incubation under stirring for 12 h at room temperature, 1 mL of iodomethane was added slowly into the above polysaccharide solution; the solution was kept under incubation in the dark for 5 h at room temperature. After that, it was dialyzed against flowing tap-water in a dialysis tube (with a molecular size cutoff at 1000 Da) for 24 h. The methylated polysaccharide was extracted three times with chloroform (2 mL each time); the chloroform extract was combined and dried using a reduced-pressure rotary evaporator. The above procedure was repeated three times, and the completeness of methylation was confirmed when the detection of the hydroxyl absorption in the IR spectrum failed. The methylated polysaccharide was hydrolyzed within 2 M TFA (2 mL); then, the generated methylated alditol acetates were analyzed by GC-MS. The temperature programming condition of GC was as follows: the column temperature of the column was initially 140 °C and was increased to 180 °C at 2 °C/min, then to 190 °C at 1 °C/min and to 280 °C at 10 °C/min and held for 5 min. The gas chromatograph was operated in split mode with the split/splitless injector at the ratio of 1:5. The injector temperature was set at 250 °C. The MS progress started at 5 min and ended at 44 min. Standard monosaccharide were carried out following the same procedure.

3.7. Partial Acid Hydrolysis {#sec3dot7-molecules-21-00779}
----------------------------

BP1 (50 mg) was dissolved in 5 mL of TFA (0.1 M) at 60 °C for 1 h. The hydrolysate solution was evaporated under reduced pressure, and MeOH was added into the residue to remove TFA. The product was lyophilized and dissolved in ultra-pure water. The degraded polysaccharide was isolated from the hydrolysis products by ethanol precipitation and was named BP1a, which was examined using HPGPC before the NMR test \[[@B44-molecules-21-00779]\].

3.8. NMR Analysis {#sec3dot8-molecules-21-00779}
-----------------

The ^1^H-NMR (400 MHz), ^13^C-NMR (100 MHz), 2D-NMR, including ^1^H-^1^H correlation spectroscopy (COSY), heteronuclear single-quantum coherence (HSQC) and heteronuclear multiple bond correlation (HMBC) spectra of BP1, were obtained on a Bruker Avance 400 spectrometer (Bruker BioSpin, Rheinstetten, Germany). BP1 (40 mg) was dissolved in 1 mL of D~2~O (99.9% D) and freeze-dried to complete deuterium exchange. The treated sample was dissolved again in 400 μL of D~2~O (99.9% D) to make the sample solution. Acetone was used as the internal standard (δ~H~ 2.225 ppm, δ~C~ 31.45 ppm). The Bruker TopSpin program was used to acquire and process the NMR data.

3.9. MTT Assay {#sec3dot9-molecules-21-00779}
--------------

The effect of BP1 on the proliferation of RAW 264.7 cells was measured using the MTT (3-\[4,5-dimethylthiazol\]-2,5-diphenyltetrazolium bromide, Sigma-Aldrich stain assay. Cells (1 × 10^4^ cells/well) were seeded in 96-well plates (Corning Inc., Corning, New York, NY, USA) and cultured overnight; they were then incubated with different concentrations of BP1 plus polymyxin B (PolyB 10 μg/mL, used to suppress the effect of LPS) for 24 h. LPS (2 μg/mL) and LPS plus PolyB (10 μg/mL) were used as controls. Following incubation, 30 µL of MTT solution (5 mg/mL in PBS) were added to each well, and the plates were incubated at 37 °C for another 4 h. Then, the medium was discarded, and 150 µL of dimethyl sulfoxide was added to dissolve the formazan crystals. The absorbance of each sample was read at 490 nm using a microplate reader (Thermo, Waltham, MA, USA).

3.10. Nitrite Assay {#sec3dot10-molecules-21-00779}
-------------------

RAW 264.7 macrophages were seeded on a 24-well plate at the initial concentration of 2 × 10^5^ cells/well overnight. The cells were treated with 12.5, 25, 50 and 100 µg/mL of BP1 for 24 h. PolyB was added to the cells in order to monitor the impact of LPS. LPS (2 μg/mL) and LPS plus PolyB were used as controls. The production of NO was determined by assaying the accumulation of nitrite, in the culture medium having Griess reagent (Sigma-Aldrich). The nitrite concentration was calculated by comparison with standard sodium nitrite solutions by spectrophotometry, at 540 nm.

3.11. Cytokine Determination and the Effect of Toll-Like Receptor 4 Inhibitor {#sec3dot11-molecules-21-00779}
-----------------------------------------------------------------------------

The production of tumor necrosis factor-alpha (TNF-α) and interleukin -6 (IL-6) was measured by using an ELISA kit (eBioscience, San Diego, CA, USA). Briefly, RAW 264.7 macrophages were seeded overnight on a 24-well plate at the initial concentration of 2 × 10^5^ cells/well. In the groups treated with TLR 4 inhibitor or TLR 4 inhibitor control (Novus Biologicals, Littleton, CO, USA), the cells were pretreated with TLR 4 inhibitor or its control and incubated at 37 °C, in an atmosphere of 5% CO~2~. One hour later, PolyB plus different concentrations of BP1 were added to the medium (system), and the cells were incubated for another 24 h. LPS (2 μg/mL) and LPS plus PolyB were used as controls. Cell-free supernatants were collected for the ELISA assay.

3.12. Phagocytic Assay {#sec3dot12-molecules-21-00779}
----------------------

Fluorescein isothiocyanate-conjugated dextran (FITC-dextran, Mw 12,000) was prepared for the phagocytic assay according to a published study \[[@B45-molecules-21-00779]\]. RAW 264.7 macrophages (4 × 10^5^ cells/well) were seeded in 12-well plates overnight and were then exposed to the various concentrations of 12.5, 25, 50 and 100 µg/mL of BP1 for 24 h, in which PolyB (10 μg/mL) was added to all of the cells in order to suppress the impact of LPS. LPS (2 μg/mL) and LPS plus PolyB (10 μg/mL) were tested as controls. After that, all of the media were removed, and the cells were treated with FITC-dextran (0.1 mg/mL), which was dissolved in the cell culture medium and incubated for 1 h at 37 °C in an atmosphere of 5% CO~2~. After incubation, cells were washed four times in cold phosphate-buffered saline (PBS) and were analyzed by flow cytometry (BD Biosciences, San Jose, CA, USA).

3.13. Data Analysis {#sec3dot13-molecules-21-00779}
-------------------

All of the results were expressed as the mean ± SD/SEM. Statistical analysis was performed using one-way ANOVA. Data analysis was performed using GraphPad PRISM software Version 5.0 (GraphPad Software, San Diego, CA, USA). A value of *p* \< 0.05 was chosen as the criterion of statistical significance.

4. Conclusions {#sec4-molecules-21-00779}
==============

A neutral α-glucan, named BP1, with a molecular mass of approximately 9.45 kDa was isolated from *Lobelia chinensis*. Its backbone mainly consists a ~6~α-[d]{.smallcaps}-Glcp^1^ linkage. The side chains are terminal α-[d]{.smallcaps}-Glcp^1^→ and α-[d]{.smallcaps}-Glcp^1^→(~6~α-[d]{.smallcaps}-Glcp^1^)~z~→~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→, which are attached to the backbone at O-3 of ~3,6~α-[d]{.smallcaps}-Glcp^1^. BP1 is able to enhance the cell proliferation, phagocytosis, nitric oxide production and cytokine secretion of RAW 264.7 cells in a dose-dependent manner. These effects might be mediated via TLR4, as the inhibitor of TLR4 is able to block the BP1-induced secretion of TNF-α and IL-6.
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![(**A**) The Q-Sepharose column chromatography of crude polysaccharide extracted from *Lobelia chinensis*; (**B**) gel filtration chromatography of the major fraction (0.2 NaCl elution) on Superdex 75; (**C**) homogeneity of BP1 as measured by high performance gel permeation chromatography (HPGPC); (**D**) monosaccharide composition of BP1 (upper: reference standards; lower: BP1).](molecules-21-00779-g001){#molecules-21-00779-f001}

![1D-NMR spectra of BP1. (**A**) ^1^H-NMR; (**B**) ^13^C-NMR; (**C**) DEPT135-NMR and (**D**) ^13^C-NMR of BP1a. The signals highlighted in red indicate the changes of C1, C3 of ~3~α-[d]{.smallcaps}-Glcp^1^ and C4 of ~4~α-[d]{.smallcaps}-Glcp^1^ caused by partial acid hydrolysis.](molecules-21-00779-g002){#molecules-21-00779-f002}

![HMBC spectra of BP1: The inter-residue ^1^H-^13^C long-range correlations used for linkage and sequence assignments are listed in [Table 3](#molecules-21-00779-t003){ref-type="table"}.](molecules-21-00779-g003){#molecules-21-00779-f003}

![NOESY spectrum of BP1. NOE correlations are labelled with residue and proton/carbon numbers, as listed in [Table 4](#molecules-21-00779-t004){ref-type="table"}.](molecules-21-00779-g004){#molecules-21-00779-f004}

![2D-NMR spectrum of BP1. (**A**) 1H-1H COSY spectra of BP1; (**B**) HSQC spectra of BP1. The cross-peaks are labelled with the residue and number; residue names are the same as those in [Table 2](#molecules-21-00779-t002){ref-type="table"}.](molecules-21-00779-g005){#molecules-21-00779-f005}

![The proposed chemical structure of BP1. (**A**) ~6~α-[d]{.smallcaps}-Glcp^1^; (**B**) ~3,6~α-[d]{.smallcaps}-Glcp^1^; (**C**) ~4~α-[d]{.smallcaps}-Glcp^1^; (**D**) ~3~α-[d]{.smallcaps}-Glcp^1^; (**E**) α-[d]{.smallcaps}-Glcp^1^. The symbols of x, y and z were used to express the number of ~6~α-[d]{.smallcaps}-Glcp^1^.](molecules-21-00779-g006){#molecules-21-00779-f006}

![Immunomodulating effects of BP1. (**A**) Dose-dependent induction of the proliferation of RAW 264.7 cells; (**B**) dose-dependent effect on the production of NO by RAW 264.7 cells *in vitro*; (**C**) induction of RAW 264.7 cell TNF-α secretion *in vitro*, and the role of TLR4 in this bioactivity; (**D**) Induction of RAW 264.7 cell IL-6 secretion *in vitro*, and the role of TLR4 in this bioactivity. LPS (2 µg/mL) and LPS + polymyxin B (PolyB) served as the positive control and endotoxin-excluded control, respectively. Each value is expressed as the mean ± SD (*n* = 3). Level of significance: \*\* *p* \< 0.01; \*\*\* *p* \< 0.001 compared to untreated cells (at 0 µg/mL).](molecules-21-00779-g007){#molecules-21-00779-f007}

![Inducing the effect of BP1 on the phagocytosis to FITC-labeled dextran (12 kDa) by RAW 264.7 cells in a dose-dependent manner. LPS (2 µg/mL) and LPS + polymyxin B served as the positive control and endotoxin-excluded control, respectively. Each value is expressed as the mean ± SD (*n* = 3). Level of significance: \* *p* \< 0.05, \*\* *p* \< 0.01 compared to untreated cells (at 0 µg/mL).](molecules-21-00779-g008){#molecules-21-00779-f008}

molecules-21-00779-t001_Table 1

###### 

Linkages and individual molar ratios of BP1 elucidated by methylation analysis.

  Methylation Sugars   Linkages    Retention Time (min)   Molar Ratio   Main Mass Fragment (*m*/*z* \*, Intensity %)
  -------------------- ----------- ---------------------- ------------- ----------------------------------------------------------------------------------------------------------
  2,3,4,6-Me4-Glcp     Glc-1       28.358                 2.01          43 (100), 71 (20), 87 (25), 101 (65), 117 (50), 129 (48), 145 (40), 161 (45), 205 (10)
  2,3,4-Me3-Glcp       Glc-1,6     36.061                 5.97          43 (100), 71 (15), 87 (33), 99 (40), 101 (52), 117 (55), 129 (37), 161 (15), 173 (5), 189 (10), 233 (10)
  2,3,6-Me3-Glcp       Glc-1,4     34.539                 2.03          43 (100), 71 (5), 87 (18), 99 (15), 101 (20), 113 (15), 117 (45), 129 (5), 161 (3), 233 (20)
  2,4,6-Me3-Glcp       Glc-1,3     33.862                 0.99          43 (100), 71 (16), 87 (25), 99 (15), 101 (38), 113 (5), 117 (85), 129 (70), 161 (30), 173 (5), 233 (10)
  2,4-Me2-Glcp         Glc-1,3,6   42.231                 2.01          43 (100), 71 (5), 87 (25), 99 (10), 101 (5), 117 (32), 129 (45), 189 (15), 233 (5)

**\*** The symbol *m* stands for mass and *z* stands for the charge number of ions. *m*/*z* represents mass divided by charge number.

molecules-21-00779-t002_Table 2

###### 

Signal assignments of the ^1^H- and ^13^C-NMR spectra of BP1 based on the analysis of H-HCOSY, HSQC and HMBC spectra \[[@B21-molecules-21-00779],[@B22-molecules-21-00779],[@B23-molecules-21-00779],[@B24-molecules-21-00779]\].

  Glycosyl Residues                   C1           C2           C3           C4           C5           C6           
  ----------------------------------- ------------ ------------ ------------ ------------ ------------ ------------ --
  A: ~6~α-[d]{.smallcaps}-Glcp^1^     99.0         73.1         74.3         70.8         71.4         66.8         
  4.85\~4.90                          3.44\~3.48   3.60\~3.64   3.40\~3.43   3.80\~3.83   3.64\~3.66   3.86\~3.90   
  B: ~3,6~α-[d]{.smallcaps}-Glcp^1^   98.9         72.4         81.7         74.1         70.6         66.6         
  4.88\~4.91                          3.54\~3.59   3.73\~3.77   3.89\~3.93   3.33\~3.37   3.58\~3.67   3.86\~3.90   
  C: ~4~α-[d]{.smallcaps}-Glcp^1^     101.0        71.4         74.6         78.0         71.6         61.8         
  5.29\~5.32                          3.52\~3.54   3.84\~3.88   3.55\~3.58   3.73\~3.77   3.67\~3.69   3.73\~3.75   
  D: ~3~α-[d]{.smallcaps}-Glcp^1^     100.8        72.4         82.3         71.4         74.3         61.8         
  5.28\~5.30                          3.49\~3.50   3.73\~3.77   3.36\~3.38   3.62\~3.66   3.67\~3.69   3.73\~3.75   
  E: α-[d]{.smallcaps}-Glcp^1^        100.6        72.7         71.4         73.9         71.5         61.6         
  5.22\~5.26                          3.44\~3.48   4.09\~4.12   3.89\~3.92   3.34\~3.38   3.67\~3.69   3.73\~3.75   

molecules-21-00779-t003_Table 3

###### 

The significant ^3^*J*~H,C~ correlations observed in the HMBC spectrum of BP1.

  No.    Glycosyl Residues                Atom      Residue   δ~C~   Atom       Residue      δ~H~
  ------ -------------------------------- --------- --------- ------ ---------- ------------ ------------
  A      ~6~α-[d]{.smallcaps}-Glcp^1^     AH1       AC3 ^a^   74.6   AC1        AH2          3.44\~3.48
  4.88   AH1                              AC5 ^a^   71.4      AC1    AH6a       3.64\~3.66   
         AH1                              AC6       66.8      AC1    BH6a ^b^   3.56\~3.61   
         AH1                              BC3       81.7      AC1    CC3        3.84\~3.88   
         AH1                              BC6 ^b^   66.6                                     
         AH1                              CC2       71.4                                     
         AH1                              CC3       74.6                                     
  B      ~3,6~α-[d]{.smallcaps}-Glcp^1^   BH1       AC2       73.1   BC1        AH6a ^c^     3.64\~3.66
  4.87   BH1                              AC4       70.8      BC1    BH6a       3.56\~3.61   
         BH1                              AC6 ^c^   66.8                                     
         BH1                              BC3 ^a^   81.7                                     
         BH1                              BC5 ^a^   70.6                                     
         BH1                              BC6       66.6                                     
  C      ~4~α-[d]{.smallcaps}-Glcp^1^     CH1       BC2       72.4   CC1        DH3 ^d^      3.73\~3.77
  5.31   CH1                              BC3 ^e^   74.6      CC1    BH3 ^e^    3.73\~3.77   
         CH1                              DC2       72.4      CC1    CH4        3.57\~3.58   
         CH1                              CC4       78.0                                     
  D      ~3~α-[d]{.smallcaps}-Glcp^1^     DH1       BC2       72.4   DC1        CH4 ^f^      3.57\~3.58
  5.29   DH1                              CC3       74.6                                     
         DH1                              DC2       72.4                                     
         DH1                              CC4 ^f^   78.0                                     
  E      α-[d]{.smallcaps}-Glcp^1^        EH1       BC4       74.1   EC1        BH3 ^g^      3.73\~3.77

^a^ For the presence of α-configurations; ^b^ For →~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^→; ^c^ For →~6,3~α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^; ^d^ For →~4~α-[d]{.smallcaps}-Glcp^1^→~3~α-[d]{.smallcaps}-Glcp^1^→; ^e^ For →~4~α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^→; ^f^ For →~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→; ^g^ For α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^→.

molecules-21-00779-t004_Table 4

###### 

Assignment of the NOESY spectra of BP1.

  Anomeric Proton   NOE Contact Proton   δH           Glycosyl Residue
  ----------------- -------------------- ------------ ---------------------------------------------------------------
  AH1               AH2                  3.44\~3.48   
                    AH5                  3.80\~3.83   
                    AH6a                 3.64\~3.66   
                    AH6b                 3.88\~3.90   
                    BH6a                 3.59\~3.61   →~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^→
                    BH6b                 3.88\~3.90   →~6~α-[d]{.smallcaps}-Glcp^1^→~6,3~α-[d]{.smallcaps}-Glcp^1^→
                    CH4                  3.57\~3.58   →~6~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→
  BH1               BH2                  3.54\~3.59   
                    BH3                  3.73\~3.77   
  CH1               CH2                  3.52\~3.54   
                    CH3                  3.73\~3.77   
                    BH3                  3.73\~3.77   
  DH1               CH4                  3.57\~3.58   →~3~α-[d]{.smallcaps}-Glcp^1^→~4~α-[d]{.smallcaps}-Glcp^1^→
  DH1               CH3                  3.84\~3.88   
  EH1               BH3                  3.73\~3.77   α-[d]{.smallcaps}-Glcp^1^→~3,6~α-[d]{.smallcaps}-Glcp^1^→
                    AH2                  3.44\~3.48   
                    AH3                  3.60\~3.64   
                    AH6a                 3.64\~3.66   α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^→
                    AH6b                 3.88\~3.90   α-[d]{.smallcaps}-Glcp^1^→~6~α-[d]{.smallcaps}-Glcp^1^→
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